boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Biology版 - Broad目前握有专利,但CRISPR的专利之争似乎有利于UC?
相关主题
Zinc Finger Nuclease或者TALE 能用来做Knockin么?
2015 Breakthrough Prizes 授奖Crispr,没 feng zhang啊
Fight over the patents for CRISPR
Emmanuelle Charpentier算屌丝逆袭吗?
Feng Zhang CRISPR Patent Fight
Crispr或张峰今年会不会获诺奖?
Human genome editing
韩春雨的阿狗, 决不是什么小事
张锋获2016年加拿大“小诺贝尔奖”
国际媒体对韩春雨NgAgo论文被撤的反应
相关话题的讨论汇总
话题: uspto话题: patent话题: broad话题: university话题: california
进入Biology版参与讨论
1 (共1页)
m***T
发帖数: 11058
1
USPTO Declares Interference Proceeding to Adjudicate CRISPR Patent Spat
Jan 12, 2016 | a GenomeWeb staff reporter
NEW YORK (GenomeWeb) – The US Patent and Trademark Office yesterday
declared an interference proceeding to settle certain claims related to the
CRISPR patent battle between parties led by the Broad Institute and the
University of California, respectively.
In the interference proceedings, the USPTO will collect, consider, and
compare historical documentary evidence to establish invention dates.
Because the applications were filed before the US moved to a "first to file"
patent system in 2013, the patent rights will be granted under the old "
first to invent" system.
In a document declaring the interference, the USPTO named the University of
California as the senior party, effectively placing the burden on the Broad
Institute to establish that it invented the technology first, even though
the USPTO granted it the first CRISPR-related patent in April 2014.
The announcement comes after the University of California requested in April
2015 that the USPTO initiate an interference.
The USPTO has awarded the Broad Institute more than a dozen CRISPR-related
patents based on the work of Feng Zhang, a core faculty member at the Broad
Institute and assistant professor at the Massachusetts Institute of
Technology, and his colleagues — notably Fei Ann Ran, a postdoc in Zhang's
lab. The University of California submitted its patent application first,
based on the work of UC-Berkeley Professor Jennifer Doudna and Emmanuelle
Charpentier, then at Sweden's Umeå University; however, the Broad
application was reviewed and awarded under the USPTO's "accelerated
examination" procedures.
In a statement, the Broad Institute said that by awarding US Patent 8,697,
359 to the Broad, MIT and Zhang, the USPTO "was fully aware of and fully
considered the claims and materials in the other patent applications,"
including UC-Berkeley's. The University of California's patent application
claims a priority date of May 25, 2012.
Administrative Patent Judge Deborah Katz will manage the proceedings. Vedder
Price will act as counsel to the Broad Institute. Buchanan, Ingersoll &
Rooney and Goodwin Procter will serve as counsel for the party led by the
University of California.
The parties will participate in an initial conference call on March 9.
According to the USPTO, the senior party — the University of California —
is responsible for initiating settlement discussions.
m***T
发帖数: 11058
2
链接在这里
https://www.genomeweb.com/business-news/uspto-declares-interference-
proceeding-adjudicate-crispr-patent-spat?utm_source=SilverpopMailing&utm_
medium=email&utm_campaign=Daily%20News:%20USPTO%20Declares%20Interference%
20Proceeding%20to%20Adjudicate%20CRISPR%20Patent%20Spat%20-%2001/12/2016%
2003:55:00%20PM
m***T
发帖数: 11058
3
当然最后结果还不好说
m*********9
发帖数: 232
4
看了BI的,prior date是12年12月12号,那的确是他们不占优势,人家UCB的是12年5月。
不过USPTO这是要上传说中十多年见不到一起的102(g)了吗?
而且话说,这估计是历史上最后一个102(g)了啊,收官巨作的节奏。
看这架势USPTO撕完之后估计还得继续向上撕啊……坐等打到高院!
哈哈哈,BI的律师的所还真的正在招生物背景的NY bar attorney……
l****y
发帖数: 398
5
八成会settle
[在 medIT (Runner-行者) 的大作中提到:]


:...........
1 (共1页)
进入Biology版参与讨论
相关主题
国际媒体对韩春雨NgAgo论文被撤的反应
CRISPR相关的公司
大家对feng zhang的公司Editas怎么看?
zz The Heroes of CRISPR by Eric Lander
我来为张锋说句公道话
crispr 诺奖预测
现在庆祝为时尚早,张锋CRISPR基因编辑专利仍然会被无效的!
今天Nature这篇siDNA的文章大家有没有兴趣发散一下
Feng Zhang: The Midas of Methods
Broad张峰实在太厉害了
相关话题的讨论汇总
话题: uspto话题: patent话题: broad话题: university话题: california